133 related articles for article (PubMed ID: 32987131)
21. Rutin improves functional outcome via reducing the elevated matrix metalloproteinase-9 level in a photothrombotic focal ischemic model of rats.
Jang JW; Lee JK; Hur H; Kim TW; Joo SP; Piao MS
J Neurol Sci; 2014 Apr; 339(1-2):75-80. PubMed ID: 24507948
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinase induction by EMMPRIN in experimental focal cerebral ischemia.
Burggraf D; Liebetrau M; Martens HK; Wunderlich N; Jäger G; Dichgans M; Hamann GF
Eur J Neurosci; 2005 Jul; 22(1):273-7. PubMed ID: 16029217
[TBL] [Abstract][Full Text] [Related]
23. Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.
Singh S; Houng AK; Reed GL
Neuroscience; 2018 Apr; 376():40-47. PubMed ID: 29294343
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of EMMPRIN after permanent focal cerebral ischemia.
Zhu W; Khachi S; Hao Q; Shen F; Young WL; Yang GY; Chen Y
Neurochem Int; 2008 May; 52(6):1086-91. PubMed ID: 18164515
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes.
Muir EM; Adcock KH; Morgenstern DA; Clayton R; von Stillfried N; Rhodes K; Ellis C; Fawcett JW; Rogers JH
Brain Res Mol Brain Res; 2002 Apr; 100(1-2):103-17. PubMed ID: 12008026
[TBL] [Abstract][Full Text] [Related]
26. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.
Rosell A; Alvarez-Sabín J; Arenillas JF; Rovira A; Delgado P; Fernández-Cadenas I; Penalba A; Molina CA; Montaner J
Stroke; 2005 Jul; 36(7):1415-20. PubMed ID: 15947272
[TBL] [Abstract][Full Text] [Related]
27. Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3, Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5-deficient mice.
Luckow B; Joergensen J; Chilla S; Li JP; Henger A; Kiss E; Wieczorek G; Roth L; Hartmann N; Hoffmann R; Kretzler M; Nelson PJ; Pérez de Lema G; Maier H; Wurst W; Balling R; Pfeffer K; Gröne HJ; Schlöndorff D; Zerwes HG
Eur J Immunol; 2004 Sep; 34(9):2568-78. PubMed ID: 15307189
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.
Li X; Tai HH
Curr Cancer Drug Targets; 2012 Jul; 12(6):703-15. PubMed ID: 22515524
[TBL] [Abstract][Full Text] [Related]
29. Mindin is a critical mediator of ischemic brain injury in an experimental stroke model.
Wang L; Lu Y; Zhang X; Zhang Y; Jiang D; Dong X; Deng S; Yang L; Guan Y; Zhu L; Zhou Y; Zhang X; Li H
Exp Neurol; 2013 Sep; 247():506-16. PubMed ID: 23360804
[TBL] [Abstract][Full Text] [Related]
30. Comparison of matrix metalloproteinase activation after focal cortical ischemia in young adult and aged mice.
Liguz-Lecznar M; Ziemka-Nalecz M; Aleksy M; Kossut M; Skangiel-Kramska J; Nowicka D
J Neurosci Res; 2012 Jan; 90(1):203-12. PubMed ID: 21922513
[TBL] [Abstract][Full Text] [Related]
31. Plasma Matrix Metalloproteinases in Patients With Stroke During Intensive Rehabilitation Therapy.
Ma F; Rodriguez S; Buxo X; Morancho A; Riba-Llena I; Carrera A; Bustamante A; Giralt D; Montaner J; Martinez C; Bori I; Rosell A
Arch Phys Med Rehabil; 2016 Nov; 97(11):1832-1840. PubMed ID: 27373742
[TBL] [Abstract][Full Text] [Related]
32. Quercetin reduces the elevated matrix metalloproteinases-9 level and improves functional outcome after cerebral focal ischemia in rats.
Lee JK; Kwak HJ; Piao MS; Jang JW; Kim SH; Kim HS
Acta Neurochir (Wien); 2011 Jun; 153(6):1321-9; discussion 1329. PubMed ID: 21120545
[TBL] [Abstract][Full Text] [Related]
33. MMP-12 as a potential biomarker to forecast ischemic stroke in obese patients.
Wang CY; Zhang CP; Li BJ; Jiang SS; He WH; Long SY; Tian Y
Med Hypotheses; 2020 Mar; 136():109524. PubMed ID: 31862687
[TBL] [Abstract][Full Text] [Related]
34. White matter damage is associated with matrix metalloproteinases in vascular dementia.
Rosenberg GA; Sullivan N; Esiri MM
Stroke; 2001 May; 32(5):1162-8. PubMed ID: 11340226
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases contribute to the regulation of chemokine expression and pulmonary inflammation in Cryptococcus infection.
Supasorn O; Sringkarin N; Srimanote P; Angkasekwinai P
Clin Exp Immunol; 2016 Mar; 183(3):431-40. PubMed ID: 26445891
[TBL] [Abstract][Full Text] [Related]
36. Early upregulation of matrix metalloproteinases following reperfusion triggers neuroinflammatory mediators in brain ischemia in rat.
Amantea D; Russo R; Gliozzi M; Fratto V; Berliocchi L; Bagetta G; Bernardi G; Corasaniti MT
Int Rev Neurobiol; 2007; 82():149-69. PubMed ID: 17678960
[TBL] [Abstract][Full Text] [Related]
37. Post-transcriptional inactivation of matrix metalloproteinase-12 after focal cerebral ischemia attenuates brain damage.
Chelluboina B; Warhekar A; Dillard M; Klopfenstein JD; Pinson DM; Wang DZ; Veeravalli KK
Sci Rep; 2015 May; 5():9504. PubMed ID: 25955565
[TBL] [Abstract][Full Text] [Related]
38. Osmoprotectants suppress the production and activity of matrix metalloproteinases induced by hyperosmolarity in primary human corneal epithelial cells.
Deng R; Su Z; Hua X; Zhang Z; Li DQ; Pflugfelder SC
Mol Vis; 2014; 20():1243-52. PubMed ID: 25352733
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
Dong W; Li N; Gao D; Zhen H; Zhang X; Li F
J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362
[TBL] [Abstract][Full Text] [Related]
40. Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes.
Ge X; Ma X; Meng J; Zhang C; Ma K; Zhou C
Arthritis Rheum; 2009 Sep; 60(9):2714-22. PubMed ID: 19714632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
